PMC7374225_01
Schematic representation depicting the use of sleep and behavioral medications in a preschooler with SATB2-associated syndrome.
CRIG2020-8868458.001.jpg
PMC7374225_01_CRIG2020-8868458.001.jpg
fig1
His medications at the time of initial presentation included levetiracetam 250 mg twice daily, clonidine 0.1 mg at bedtime, and melatonin 5 mg at around 8 pm (Figure 1).
PMC7374225_02